Actively Recruiting
Effects of a Tailored, Optimised, Person-centred Lifestyle Program to Improve Metabolic Syndrome Control
Led by The University of Hong Kong · Updated on 2026-02-02
152
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a lifestyle modification program to improve control of metabolic syndrome in Chinese adults. This mixed-methods study includes a 2-arm randomized controlled trial and a qualitative study. The metabolic syndrome is defined by having three or more abnormal findings among raised blood pressure, triglycerides, lowered HDL cholesterol, fasting blood glucose, and central obesity. Assessments will be done at the start, after 12 weeks of active intervention, and again at 20 weeks. Participants will be randomly assigned to either the intervention group receiving a 12-week tailored, nurse-led, person-centred program aimed at promoting sustainable lifestyle changes, or the control group receiving a one-time 15-minute structured lifestyle advice session. The study is conducted in multiple community centers and focuses on promoting health behaviors and metabolic improvements. During the study, participants will complete various assessments including the Health-Promoting Lifestyle Profile-II, measurements of metabolic syndrome components such as BMI, blood pressure, triglycerides, HDL, fasting blood glucose, waist circumference, and health-related quality of life using the SF-12v2 survey. Blood lipids and glucose will be measured with a portable point-of-care analyzer. Outcomes will be tracked at baseline, 12 weeks, and 20 weeks to evaluate changes and metabolic syndrome reversal.
CONDITIONS
Brief Title
A Tailored, Optimised, and Person-centred Programme to Promote Lifestyle Modification in People With Metabolic Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese adults with metabolic syndrome defined by having three or more abnormal findings among raised blood pressure, raised triglycerides, lowered HDL cholesterol, raised fasting blood glucose, and central obesity
- Aged 18 years or older
- Living independently in the community
- Able to perform daily living activities independently
- Possess a digital device with internet connection
You will not qualify if you...
- History of established atherosclerotic cardiovascular diseases such as coronary heart disease, cerebrovascular disease, or peripheral arterial disease
- Diagnosed psychiatric diseases
- Unable to read Chinese
- Impaired communication or cognitive function, indicated by an Abbreviated Mental Test Score of 6 or less
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive either a 12-week tailored, optimised, and person-centred lifestyle modification programme or a once-off 15-minute structured lifestyle education.
Weekly visits for up to 12 weeks
Duration - 8 weeks
Participants are monitored for maintenance of lifestyle changes and metabolic syndrome status after completing the active intervention.
1 visit at 20 weeks after baseline
Trial Site Locations
Total: 1 location
1
Local community centres
Hong Kong, Hong Kong
Actively Recruiting
Research Team
B
Bernice Chan
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here